A model of type 1 diabetes was induced by streptozotocin (STZ) treatment, which is characterized by a nearly total loss of insulin producing beta cells, insulin secretion and significantly increased blood glucose concentrations ([22], Figure S2). Here, INS is linked to type 1 diabetes mellitus.